BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22264909)

  • 1. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
    Heneghan HM; Huang H; Kashyap SR; Gornik HL; McCullough AJ; Schauer PR; Brethauer SA; Kirwan JP; Kasumov T
    Surg Obes Relat Dis; 2013; 9(1):100-7. PubMed ID: 22264909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.
    Huang H; Kasumov T; Gatmaitan P; Heneghan HM; Kashyap SR; Schauer PR; Brethauer SA; Kirwan JP
    Obesity (Silver Spring); 2011 Nov; 19(11):2235-40. PubMed ID: 21546935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Bypass Surgery Improves the Skeletal Muscle Ceramide/S1P Ratio and Upregulates the AMPK/ SIRT1/ PGC-1α Pathway in Zucker Diabetic Fatty Rats.
    Huang H; Aminian A; Hassan M; Dan O; Axelrod CL; Schauer PR; Brethauer SA; Kirwan JP
    Obes Surg; 2019 Jul; 29(7):2158-2165. PubMed ID: 30809769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.
    Kayser BD; Lhomme M; Dao MC; Ichou F; Bouillot JL; Prifti E; Kontush A; Chevallier JM; Aron-Wisnewsky J; Dugail I; Clément K
    Int J Obes (Lond); 2017 Jun; 41(6):917-925. PubMed ID: 28280270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study.
    Carlsson ER; Allin KH; Madsbad S; Fenger M
    Lipids Health Dis; 2019 Sep; 18(1):169. PubMed ID: 31488158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in oxidative stress markers and cardiometabolic risk factors among Roux-en-Y gastric bypass patients after 3- and 12-months postsurgery follow-up.
    Pinto SL; Juvanhol LL; Licursi de Oliveira L; Clemente RC; Bressan J
    Surg Obes Relat Dis; 2019 Oct; 15(10):1738-1745. PubMed ID: 31495634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients.
    Brethauer SA; Heneghan HM; Eldar S; Gatmaitan P; Huang H; Kashyap S; Gornik HL; Kirwan JP; Schauer PR
    Surg Endosc; 2011 Aug; 25(8):2650-9. PubMed ID: 21416179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes.
    Kasumov T; Solomon TP; Hwang C; Huang H; Haus JM; Zhang R; Kirwan JP
    Obesity (Silver Spring); 2015 Jul; 23(7):1414-21. PubMed ID: 25966363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.
    Heffron SP; Lin BX; Parikh M; Scolaro B; Adelman SJ; Collins HL; Berger JS; Fisher EA
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):245-254. PubMed ID: 29162605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients.
    Gero D; Favre L; Allemann P; Fournier P; Demartines N; Suter M
    Obes Surg; 2018 Mar; 28(3):805-811. PubMed ID: 28971303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    Ferchaud-Roucher V; Zair Y; Aguesse A; Krempf M; Ouguerram K
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32805740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up.
    Griffo E; Cotugno M; Nosso G; Saldalamacchia G; Mangione A; Angrisani L; Rivellese AA; Capaldo B
    Obes Surg; 2016 Jun; 26(6):1247-53. PubMed ID: 26435537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
    Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
    J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity.
    Maldonado-Hernández J; Saldaña-Dávila GE; Piña-Aguero MI; Núñez-García BA; López-Alarcón MG
    Can J Gastroenterol Hepatol; 2017; 2017():3689375. PubMed ID: 28634575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.
    Brolin RE; Bradley LJ; Wilson AC; Cody RP
    J Gastrointest Surg; 2000; 4(5):464-9. PubMed ID: 11077320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
    Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
    Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).
    Wang DD; Toledo E; Hruby A; Rosner BA; Willett WC; Sun Q; Razquin C; Zheng Y; Ruiz-Canela M; Guasch-Ferré M; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Ros E; Lapetra J; Fito M; Aros F; Serra-Majem L; Lee CH; Clish CB; Liang L; Salas-Salvadó J; Martínez-González MA; Hu FB
    Circulation; 2017 May; 135(21):2028-2040. PubMed ID: 28280233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gastric bypass versus diet on cardiovascular risk factors.
    Raffaelli M; Guidone C; Callari C; Iaconelli A; Bellantone R; Mingrone G
    Ann Surg; 2014 Apr; 259(4):694-9. PubMed ID: 23979288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding.
    Woodard GA; Peraza J; Bravo S; Toplosky L; Hernandez-Boussard T; Morton JM
    Obes Surg; 2010 May; 20(5):578-82. PubMed ID: 20186576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.
    Liaskos C; Koliaki C; Alexiadou K; Argyrakopoulou G; Tentolouris N; Diamantis T; Alexandrou A; Katsilambros N; Kokkinos A
    Obes Surg; 2018 Dec; 28(12):3997-4005. PubMed ID: 30112599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.